Back to News
investment

Got $2,000? 2 Top Growth Stocks to Buy That Could Double Your Money.

newsfeedback@fool.com (Will Healy)
Loading...
5 min read
0 likes
⚡ Quantum Brief
Two retail stocks—Chewy and Target—are positioned for potential 100% gains despite recent struggles, according to analysts. Both companies show signs of recovery with strategic expansions and improving financials. Chewy’s stock has plummeted 80% from pandemic highs but continues revenue growth, projecting 6-8% annual increases. New services like Chewy Plus (a Prime-like subscription) and pet telehealth are driving expansion. Target’s new CEO is investing $5 billion to revitalize stores, supply chains, and product offerings after years of declining sales. Fiscal 2026 forecasts a 2% revenue rebound, ending a multi-year slump. Chewy’s forward P/E of 16 and Target’s 14 valuation suggest undervaluation compared to peers. Target’s 3.9% dividend yield—nearly triple the S&P 500 average—adds investor appeal during its turnaround. A $2,000 investment could buy 42 Chewy shares or 8 Target shares, offering exposure to potential doubles if recovery trajectories hold. Analysts cite operational improvements as key catalysts.
AI Audio Summary
0:00 / 0:00
Click to play
quantum computing images.jpg
Quantum News · Media Library

By Will Healy – Mar 16, 2026 at 7:05PM ESTKey PointsAlthough investors turned on Chewy stock after the pandemic, the company never stopped growing.For the first time in years, Target is on track for sales growth.When it comes to investing, small investors may only have an amount of around $2,000 to either start a portfolio or add to their holdings. While that may not sound like a lot of money, some investors have built fortunes on less, and certainly, a comparatively modest goal like doubling your money is well within reach. Admittedly, events or actions that you cannot anticipate may derail an investment thesis. Nonetheless, barring such an event, these two retail stocks are in a position to double in value. Image source: Getty Images. Chewy Although it performed well in the early part of the decade, many investors may have forgotten about Chewy (CHWY 1.37%) stock. During the pandemic, the online pet retailer surged in popularity as locked-down consumers shopped at home, and customers responded well to its low prices and focus on customer service. Unfortunately, investors turned on Chewy when more customers returned to offline shopping, and the stock became an afterthought. The stock has traded in a range since the middle of 2022, and it is down by almost 80% from its pandemic highs. ExpandNYSE: CHWYChewyToday's Change(-1.37%) $-0.35Current Price$25.12Key Data PointsMarket Cap$11BDay's Range$24.91 - $25.6152wk Range$23.06 - $48.62Volume5.4MAvg Vol7.9MGross Margin28.58% However, investors who watched more closely saw that its sales did not stop growing just because the pandemic ended. Chewy seems to have taken a page from retailers like Amazon and added new promotions and business lines. Similar to Amazon Prime, Chewy Plus offers free shipping with no minimums, 5% rewards on every order, and other exclusive offers for an annual fee. Also, Chewy has branched out into pharmaceuticals for pets, and it now offers telehealth services for pets. Amid its offerings, analysts forecast 6% revenue growth for fiscal 2025. They expect that to rise to 8% in the next fiscal year, implying that its new business initiatives will affect its financials positively. Improving valuations could bring its stock the catalyst it finally needs to begin the recovery. For now, its P/E ratio is 52, which may appear high considering the S&P 500 average of 29. Still, the forward P/E of 16 should make the stock more attractive, especially when also considering its consistent revenue growth. At today's stock price, $1,065 will buy about 42 shares, providing a starting position where investors can capitalize on a likely recovery. Target At first glance, Target (TGT 0.23%) may look like it's closer to the worst choice for doubling your money than the best. Issues such as high inventories, a lack of desirable offerings, messy stores, and controversial political stances have led to Target missing the mark with customers and investors alike over the last few years. As a result, the stock is down by over 55% from its peak in 2021. Moreover, same-store sales as well as profits have remained on a downtrend. In fiscal 2025 (ended Jan. 31), revenue of $105 billion is down 2% from year-ago levels. Also, rising expenses and higher depreciation led to a net income of $3.7 billion, a 9% decline compared to fiscal 2024. ExpandNYSE: TGTTargetToday's Change(-0.23%) $-0.27Current Price$117.07Key Data PointsMarket Cap$53BDay's Range$116.01 - $118.4152wk Range$83.44 - $126.00Volume208KAvg Vol6.7MGross Margin25.44%Dividend Yield3.87% Fortunately, the company may finally be ready for a turnaround. Michael Fiddelke, who has been with the company since 2003, became CEO on Feb. 1. He has announced plans to invest $5 billion in remodeling and reformatting stores, hiring more employees, improving its technology and supply chain efficiency, and revamping its products. Target once stood out as an "upscale discounter," and such moves could return it to its roots. Investors may also see a light at the end of the tunnel as it forecasts a sales increase of around 2% for fiscal 2026. That may not sound huge, but since net sales have fallen every year since 2022, this is a welcome change, and so far, Target stock is crushing the market as a result. Additionally, its troubles have not derailed its 54 straight years of payout hikes. With that, the dividend of $4.56 per share yearly offers a yield of 3.9%, far above the S&P 500 average of 1.2%. Finally, Target's P/E ratio of 14 is far below archrival Walmart's 46 times earnings. At today's prices, $935 will buy about eight shares, and that low valuation gives Target room to double as the stock shows signs of improvement.Read NextMar 16, 2026 •By Lawrence Rothman, CFAChewy Is Down 23% in 2026. Is This a Once-in-a-Lifetime Buying Opportunity?Mar 15, 2026 •By Geoffrey Seiler1 Growth Stock Down Nearly 50% to Buy Right NowMar 12, 2026 •By James BrumleyThe Best Stocks to Buy With $1,000 Right NowMar 7, 2026 •By Adria CiminoCould Buying Chewy Today Set You Up for Life?Mar 3, 2026 •By Will HealyIs Chewy Stock Going to $100?Feb 22, 2026 •By Timothy GreenDon't Be Fooled by Chewy's Most-Cited StatisticAbout the AuthorWill Healy is a contributing Motley Fool stock market analyst covering technology and consumer goods industries.

Before The Motley Fool, Will was a freelance writer covering stocks and personal finance for MSN Money, Yahoo! Finance, and Nasdaq. Earlier in his career, he was an expert in geographic information systems, applying spatial and IT skills to perform RF and demographic analysis in the telecom industry. He holds a bachelor’s degree in journalism from Texas A&M University and an MBA in finance and strategy from the University of Texas at Dallas.TMFWillHealyX@HealyWritingStocks MentionedChewyNYSE: CHWY$25.14(-1.30%)-$0.33WalmartNASDAQ: WMT$126.00(-0.41%)-$0.52TargetNYSE: TGT$117.07(-0.23%)-$0.27AmazonNASDAQ: AMZN$211.67(+1.93%)+$4.00*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Read Original

Tags

drug-discovery
partnership

Source Information

Source: The Motley Fool

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.